An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced Monday, a finding that could lend credence to the medical marijuana movement.

The developer, GW Pharmaceuticals, said the drug, Epidiolex, achieved the main goal of the trial, reducing convulsive seizures when compared with a placebo in patients with Dravet syndrome, a rare form of epilepsy.

If Epidiolex wins regulatory approval, it would be the first prescription drug in the United States that is extracted from marijuana.

Parents whose children with epilepsy are not being helped by conventional drugs have been flocking to try marijuana extracts, prepared by medical marijuana dispensers.

Click here to read the compete article

Andrew Pollack ~ New York Times ~

 

 

Recent News Articles

Wednesday April 24

Social Life Network's MjLink looking to shake up the cannabis sector with conference

in Finance

by Bruce Kennedy - Editor in Chief

Social LIfe Network (OTCQB:WDLF) CEO Ken Tapp and MjLink President George Jage sat down with…

2007 hits

Thursday April 25

USDA Accepting Applications For Hemp Intellectual Property Protection - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

The U.S. Department of Agriculture (USDA) announced on Wednesday that hemp cultivators can officially apply…

2026 hits

Thursday April 25

How to Grow Marijuana Sustainably With Korean Natural Farming - Cannabis News

in Culture & Arts

by Bruce Kennedy - Editor in Chief

Korean Natural Farming (KNF) is a blueprint for an alternative way to farm outdoors among…

2150 hits

Thursday April 25

Inside the Only Pot Research Farm in Washington State - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

Verda Bio won the state's first pot research license last November, giving the company special…

2107 hits

Thursday April 25

Canada: Alcohol and cannabis companies form pot-beverage group to push changes - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

A group of alcohol and cannabis companies have formed an industry alliance to push for…

2163 hits